These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 32790040)

  • 21. Paradoxical psoriasiform reactions to antitumour necrosis factor-α drugs in hidradenitis suppurativa.
    Dequidt L; Cogrel O; Guillet S; Milpied B; Darrigade AS; Beylot-Barry M; Pham-Ledard A
    Br J Dermatol; 2018 Jan; 178(1):281-283. PubMed ID: 28444990
    [No Abstract]   [Full Text] [Related]  

  • 22. Association and management of Crohn's disease plus hidradenitis suppurativa.
    dos Santos CH; Netto PO; Kawaguchi KY; Parreira Alves JA; de Alencar Souza VP; Reverdito S
    Inflamm Bowel Dis; 2012 Apr; 18(4):E801-2. PubMed ID: 21993924
    [No Abstract]   [Full Text] [Related]  

  • 23. Treatment of hidradenitis suppurativa with biologic medications.
    Lee RA; Eisen DB
    J Am Acad Dermatol; 2015 Nov; 73(5 Suppl 1):S82-8. PubMed ID: 26470624
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hidradenitis suppurativa managed with adalimumab.
    Yamauchi PS; Mau N
    J Drugs Dermatol; 2009 Feb; 8(2):181-3. PubMed ID: 19213236
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Paradoxical Hidradenitis Suppurativa in Patients Receiving TNF-α Inhibitors: Case Series, Systematic Review, and Case Meta-Analysis.
    Salvador-Rodriguez L; Montero-Vílchez T; Arias-Santiago S; Molina-Leyva A
    Dermatology; 2020; 236(4):307-313. PubMed ID: 32135533
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hidradenitis suppurativa (HS): An unrecognized paradoxical effect of biologic agents (BA) used in chronic inflammatory diseases.
    Faivre C; Villani AP; Aubin F; Lipsker D; Bottaro M; Cohen JD; Durupt F; Jeudy G; Sbidian E; Toussirot E; Badot V; Barbarot S; Debarbieux S; Delaporte E; Goegebeur G; Morel J; Nassif A; Duru G; Jullien D;
    J Am Acad Dermatol; 2016 Jun; 74(6):1153-9. PubMed ID: 26965410
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adalimumab-induced pyoderma gangrenosum in a patient with hidradenitis suppurativa: A paradoxical reaction.
    Company-Quiroga J; Alique-García S; Martínez-Morán C; Khedaoui R; Romero-Maté A; Borbujo J
    Indian J Dermatol Venereol Leprol; 2019; 85(4):422-425. PubMed ID: 31115357
    [No Abstract]   [Full Text] [Related]  

  • 28. Secukinumab-induced paradoxical hidradenitis suppurativa.
    Navarro-Triviño FJ; Sanchez-Parera R; Ruiz-Villaverde R
    Dermatol Ther; 2020 Jan; 33(1):e13150. PubMed ID: 31670893
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Successful treatment of hidradenitis suppurativa and Crohn's disease with combined guselkumab and apremilast.
    Agud-Dios M; Arroyo-Andrés J; Rubio-Muñiz C; Postigo-Lorente C
    Dermatol Ther; 2022 Oct; 35(10):e15743. PubMed ID: 35904888
    [No Abstract]   [Full Text] [Related]  

  • 30. Development of hidradenitis suppurativa in a patient treated with ustekinumab for her psoriasis: A potential paradoxical reaction?
    Gkini MA; Bewley AP
    Dermatol Ther; 2018 Nov; 31(6):e12742. PubMed ID: 30221819
    [No Abstract]   [Full Text] [Related]  

  • 31. Case of bullous pemphigoid under treatment with adalimumab for hidradenitis suppurativa.
    Sugaya M; Ishii M; Takahashi-Shishido N; Ichimura Y; Morimura S
    J Dermatol; 2021 Apr; 48(4):e163-e164. PubMed ID: 33502014
    [No Abstract]   [Full Text] [Related]  

  • 32. Twenty-four-week interim analysis from a phase 3 open-label trial of adalimumab in Japanese patients with moderate to severe hidradenitis suppurativa.
    Morita A; Takahashi H; Ozawa K; Imafuku S; Nakama T; Takahashi K; Matsuyama T; Okubo Y; Kitamura S; Matsuda N; Zhao Y; Yokoyama M; Hayashi N; Terui T
    J Dermatol; 2019 Sep; 46(9):745-751. PubMed ID: 31282051
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Paradoxical Reactions: Anti-Tumor Necrosis Factor Alpha Agents, Ustekinumab, Secukinumab, Ixekizumab, and Others.
    Puig L
    Curr Probl Dermatol; 2018; 53():49-63. PubMed ID: 29131037
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Is it worthy to treat hidradenitis suppurativa with adalimumab in patients with melanoma and other debilitating systemic diseases? A series of clinical dilemmas.
    Zhao CY; Fernández-Peñas P
    Australas J Dermatol; 2018 Nov; 59(4):e297-e298. PubMed ID: 29672833
    [No Abstract]   [Full Text] [Related]  

  • 35. Inverse psoriasis on pre-existing hidradenitis suppurativa lesions: Reply to "A case series of tumor necrosis factor inhibitor-induced psoriasis in patients with hidradenitis suppurativa".
    Baskurt D; Dogan PE; Mericoz CA; Demirkesen C; Vural S
    Dermatol Online J; 2024 Jun; 30(3):. PubMed ID: 39090054
    [No Abstract]   [Full Text] [Related]  

  • 36. Successful use of guselkumab in the treatment of severe hidradenitis suppurativa.
    Kearney N; Byrne N; Kirby B; Hughes R
    Clin Exp Dermatol; 2020 Jul; 45(5):618-619. PubMed ID: 32068912
    [No Abstract]   [Full Text] [Related]  

  • 37. Severe hidradenitis suppurativa successfully treated with secukinumab.
    Głowaczewska A; Szepietowski JC; Matusiak Ł
    Dermatol Ther; 2020 Nov; 33(6):e13845. PubMed ID: 32544258
    [No Abstract]   [Full Text] [Related]  

  • 38. Pharmaceutical Benefits Scheme listing of adalimumab for hidradenitis suppurativa: Is hidradenitis suppurativa a life-changing drug or does lifestyle change the drug?
    Vekic DA; Frew JW
    Australas J Dermatol; 2018 Aug; 59(3):e243-e244. PubMed ID: 29285755
    [No Abstract]   [Full Text] [Related]  

  • 39. Hidradenitis suppurativa and immune dysregulation.
    Jemec GB
    Br J Dermatol; 2012 Feb; 166(2):237-8. PubMed ID: 22268854
    [No Abstract]   [Full Text] [Related]  

  • 40. NICE approval of adalimumab for moderate-to-severe hidradenitis suppurativa: the end of the beginning for hidradenitis suppurativa therapeutics?
    Ingram JR; Burton T
    Br J Dermatol; 2017 Feb; 176(2):281-282. PubMed ID: 28244073
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.